Dr Lalchandani Labs Ltd

BSE: 541299

total announcements

541299.BO · 15 min delayed

BSECompany Update13 Oct 2026

certificate under Regulation 74(5) for Quarter ended September 2026

Dr Lalchandani Labs Ltd has submitted a compliance certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories & Participants) Regulations, 2018, for the quarter ended September 30, 2026, confirming the dematerialisation of securities and listing on stock exchanges.

Trading Window Closure

Dr Lalchandani Labs Ltd has announced the closure of its trading window for all directors, promoters, and connected persons from October 1, 2026, until 48 hours after the declaration of its un-audited financial results for the half year ended September 30, 2026.

The company due to ill health of the Chairman of the Company had filed the Application for extension of Annual General Meeting (AGM) for FY 2025-26, the ROC Delhi has considered and approved the application and granted the extension for the period of 3 month i.e. December 31, 2026. Therefore the Company will hold the AGM for FY 2025-26 at the earliest but not later than December 31, 2026.

Dr Lalchandani Labs Ltd has received an extension of 3 months to hold its Annual General Meeting (AGM) for FY 2025-26 due to the ill health of the Chairman, with the new date not later than December 31, 2026.